Emerging roles of Abl family tyrosine kinases in microbial pathogenesis

Trends in Biochemical Sciences

Volumn 33, Issue 2, 2008, Pages 80-90

  Backert, Steffen ^a   Feller, Stephan M ^b   Wessler, Silja ^c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ACTIN; BACTERIAL PROTEIN; TYROSINE; VIRUS PROTEIN;

ANAPLASMA PHAGOCYTOPHILUM; BACTERIAL INFECTION; CELL DIFFERENTIATION; CELL PROLIFERATION; COXSACKIE VIRUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ESCHERICHIA COLI; HELICOBACTER PYLORI; HOST CELL; HOST PATHOGEN INTERACTION; MICROBIAL ACTIVITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SHIGELLA FLEXNERI; SHIGELLOSIS; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; BACTERIA; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-ABL; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; VIRUSES;

BACTERIA (MICROORGANISMS);

EID: 38949197397     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2007.10.006     Document Type: Review

References (75)

1. Voss J., et al. Leukemic kinases of the Abl family - an update. Signal Trans. 1 (2001) 1-26
2. Woodring P.J., et al. Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J. Cell Sci. 116 (2003) 2613-2626
3. Hernandez S.E., et al. How do Abl family kinases regulate cell shape and movement?. Trends Cell Biol. 14 (2004) 36-44
4. Hantschel O., and Superti-Furga G. Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat. Rev. Mol. Cell Biol. 5 (2004) 33-44
5. Shishido T., and Suzuki J. Regulation of Abl kinases by adaptor proteins. Gene Ther. Mol. Biol. 9 (2005) 339-342
6. Hantschel O., et al. A myristoyl/phosphotyrosine switch regulates c-Abl. Cell 112 (2003) 845-857
7. Nagar B., et al. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112 (2003) 859-871
8. Plattner R., et al. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1. Nat. Cell Biol. 5 (2003) 309-319
9. Tanis K.Q., et al. Two distinct phosphorylation pathways have additive effects on Abl family kinase activation. Mol. Cell. Biol. 23 (2003) 3884-3896
10. Harrison S.C. Variation on an Src-like theme. Cell 112 (2003) 737-740
11. Plattner R., et al. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13 (1999) 2400-2411
12. Lewis J.M., et al. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 15174-15179
13. Lewis J.M., and Schwartz M.A. Integrins regulate the association and phosphorylation of paxillin by c-Abl. J. Biol. Chem. 273 (1998) 14225-14230
14. Mighter B.J., et al. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr. Biol. 5 (1995) 296-305
15. Feller S.M., et al. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13 (1994) 2341-2351
16. Feller S.M. Crk family adaptors-signalling complex formation and biological roles. Oncogene 20 (2001) 6348-6371
17. Kobashigawa Y., et al. Structural basis for the transforming activity of human cancer-related signalling adaptor protein CRK. Nat. Struct. Mol. Biol. 14 (2007) 503-510
18. Stuart J.R., et al. c-Abl interacts with the WAVE2 signalling complex to induce membrane ruffling and cell spreading. J. Biol. Chem. 281 (2006) 31290-31297
19. Leng Y., et al. Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1098-1103
20. Burton E.A., et al. Abl kinases regulate actin comet tail elongation via an N-WASP-dependent pathway. Mol. Cell. Biol. 25 (2005) 8834-8843
21. Stradal T.E., and Scita G. Protein complexes regulating Arp2/3-mediated actin assembly. Curr. Opin. Cell Biol. 18 (2006) 4-10
22. Burton E.A., et al. Abl tyrosine kinases are required for infection by Shigella flexneri. EMBO J. 22 (2003) 5471-5479
23. Burton E.A., et al. The Caenorhabditis elegans ABL-1 tyrosine kinase is required for Shigella flexneri pathogenesis. Appl. Environ. Microbiol. 72 (2006) 5043-5051
24. Nhieu G.T., et al. Tyrosine kinase signalling and type III effectors orchestrating Shigella invasion. Curr. Opin. Microbiol. 8 (2005) 16-20
25. Dehio C., et al. Invasion of epithelial cells by Shigella flexneri induces tyrosine phosphorylation of cortactin by a pp60c-src-mediated signalling pathway. EMBO J. 14 (1995) 2471-2482
26. Selbach M., and Backert S. Cortactin: an Achilles' heel of the actin cytoskeleton targeted by pathogens. Trends Microbiol. 13 (2005) 181-189
27. Boyle S.N., et al. A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr. Biol. 17 (2007) 445-451
28. Bougneres L., et al. Cortactin and Crk cooperate to trigger actin polymerization during Shigella invasion of epithelial cells. J. Cell Biol. 166 (2004) 225-235
29. Lommel S., et al. Actin pedestal formation by enteropathogenic Escherichia coli and intracellular motility of Shigella flexneri are abolished in N-WASP-defective cells. EMBO Rep. 2 (2001) 850-857
30. Coyne C.B., and Bergelson J.M. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124 (2006) 119-131
31. Dupraz P., et al. The murine AIDS virus Gag precursor protein binds to the SH3 domain of c-Abl. J. Virol. 71 (1997) 2615-2620
32. Backert S., and Selbach M. Tyrosine-phosphorylated bacterial effector proteins: the enemies within. Trends Microbiol. 13 (2005) 476-484
33. Songyang Z., et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373 (1995) 536-539
34. Scaplehorn N., et al. Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr. Biol. 12 (2002) 740-745
35. Reeves P.M., et al. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat. Med. 11 (2005) 731-739
36. Newsome T.P., et al. Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus. Cell. Microbiol. 8 (2006) 233-241
37. Campellone K.G., and Leong J.M. Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7. Curr. Opin. Microbiol. 6 (2003) 82-90
38. Caron E., et al. Subversion of actin dynamics by EPEC and EHEC. Curr. Opin. Microbiol. 9 (2006) 40-45
39. Dean P., et al. EPEC's weapons of mass subversion. Curr. Opin. Microbiol. 8 (2005) 28-34
40. Campellone K.G., and Leong J.M. Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol. Microbiol. 56 (2005) 416-432
41. Bommarius B., et al. Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation. Mol. Microbiol. 63 (2007) 1748-1768
42. Kalman D., et al. Enteropathogenic E. coli acts through WASP and Arp2/3 complex to form actin pedestals. Nat. Cell Biol. 1 (1999) 389-391
43. Gruenheid S., et al. Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells. Nat. Cell Biol. 3 (2001) 856-859
44. Swimm A., et al. Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals. Mol. Biol. Cell 15 (2004) 3520-3529
45. Goosney D.L., et al. Enteropathogenic E. coli translocated intimin receptor, Tir, interacts directly with alpha-actinin. Curr. Biol. 10 (2000) 735-738
46. Huang L., et al. Host focal adhesion protein domains that bind to the translocated intimin receptor (Tir) of enteropathogenic Escherichia coli (EPEC). Cell Motil. Cytoskeleton 52 (2002) 255-265
47. Patel A., et al. Host protein interactions with enteropathogenic Escherichia coli (EPEC): 14-3-3tau binds Tir and has a role in EPEC-induced actin polymerization. Cell. Microbiol. 8 (2006) 55-71
48. Deng W., et al. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol. Microbiol. 48 (2003) 95-115
49. Stein M., et al. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43 (2002) 971-980
50. Backert S., and Meyer T.F. Type IV secretion systems and their effectors in bacterial pathogenesis. Curr. Opin. Microbiol. 9 (2006) 207-217
51. Selbach M., et al. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277 (2002) 6775-6778
52. Tsutsumi R., et al. Attenuation of Helicobacter pylori CagA x SHP-2 signalling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem. 278 (2003) 3664-3670
53. Selbach M., et al. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 22 (2003) 515-528
54. Selbach M., et al. The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics 4 (2004) 2961-2968
55. Moese S., et al. The Helicobacter pylori CagA protein disrupts matrix adhesion of gastric epithelial cells by dephosphorylation of vinculin. Cell. Microbiol. 9 (2007) 1148-1161
56. Poppe M., et al. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 26 (2007) 3462-3472
57. Tammer I., et al. Activation of Abl by Helicobacter pylori: a novel kinase for CagA and crucial mediator of host cell scattering. Gastroenterol. 132 (2007) 1309-1319
58. Kwok T., et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449 (2007) 862-866
59. Suzuki M., et al. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J. Exp. Med. 202 (2005) 1235-1247
60. Brandt S., et al. Use of a novel coinfection system reveals a role for Rac1, H-Ras, and CrkII phosphorylation in Helicobacter pylori-induced host cell actin cytoskeletal rearrangements. FEMS Immunol. Med. Microbiol. 50 (2007) 190-205
61. Wessler S., et al. B-Raf/Rap1 signalling, but not c-Raf-1/Ras, induces the histidine decarboxylase promoter in Helicobacter pylori infection. FASEB J. 16 (2002) 417-419
62. Bourzac K.M., et al. Helicobacter pylori CagA induces AGS cell elongation through a cell retraction defect that is independent of Cdc42, Rac1, and Arp2/3. Infect. Immun. 75 (2007) 1203-1213
63. Tsutsumi R., et al. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol. Cell. Biol. 26 (2006) 261-276
64. Franco A.T., et al. Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10646-10651
65. Murata-Kamiya N., et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26 (2007) 4617-4626
66. Weydig C., et al. CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity. Exp. Cell Res. 313 (2007) 3459-3471
67. Mimuro H., et al. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell 10 (2002) 745-755
68. Brandt S., et al. NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9300-9305
69. Saadat I., et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447 (2007) 330-333
70. Park J., et al. Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell. Microbiol. 6 (2004) 743-751
71. Ijdo J.W., et al. Anaplasma phagocytophilum AnkA is tyrosine-phosphorylated at EPIYA motifs and recruits SHP-1 during early infection. Cell. Microbiol. 9 (2007) 1284-1296
72. Lin M., et al. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell. Microbiol. 9 (2007) 2644-2657
73. Ishizawar R., and Parsons S.J. c-Src and cooperating partners in human cancer. Cancer Cell 6 (2004) 209-214
74. Rix U., et al. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib reveal novel kinase and non-kinase targets. Blood 110 (2007) 4055-4063
75. Weisberg E., et al. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat. Rev. Cancer 7 (2007) 345-356